首页> 美国卫生研究院文献>Oman Medical Journal >Evaluation of HE4 CA-125 Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass

【2h】

Evaluation of HE4 CA-125 Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass

机译：附件包块患者术前评估中HE4CA-125卵巢恶性算法（ROMA）风险和恶性指数（RMI）风险的评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesTo evaluate the validity and compare the performance of cancer antigen-125 (CA-125), human epididymis protein 4 (HE4), the risk of malignancy index (RMI), and the risk of ovarian malignancy algorithm (ROMA) in the diagnosis of ovarian cancer in patients with ovarian lesions discovered during their preoperative work-up investigations.

机译：目的评估癌症抗原125（CA-125），人附睾蛋白4（HE4），恶性指数（RMI）的风险以及卵巢恶性算法（ROMA）的诊断和诊断的有效性，并进行比较。在术前检查中发现卵巢病变患者的卵巢癌。

著录项

期刊名称 Oman Medical Journal
作者
Khawla Al Musalhi; Manal Al Kindi; Faiza Al Aisary; Fatma Ramadhan; Thuraya Al Rawahi; Khalsa Al Hatali; Waad-Allah Mula-Abed;
展开▼
作者单位

展开▼
年(卷),期 2016(31),5
年度 2016
页码 336–344
总页数 9
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass [J] . KarlsenM.A., SandhuN., H?gdallC., Gynecologic Oncology: An International Journal . 2012,第2期

机译：评估HE4，CA125，卵巢恶性算法（ROMA）的风险和恶性指数（RMI）的风险作为盆腔肿块患者上皮性卵巢癌的诊断工具
2. Discriminative value of CA-125, HE4, Risk of Malignancy Index II (RMI-II) and Risk of Malignancy Algorithm (ROMA) in the differential diagnosis of pelvic masses: conclusions from a referral Centre in Portugal [J] . Melo Angela, Verissimo Renata, Farinha Margarida, Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology . 2018,第8期

机译：CA-125，HE4，恶性指数II的风险（RMI-II）的鉴别值以及恶性诊断骨盆差异诊断中恶性算法（ROMA）的风险：来自葡萄牙的推荐中心的结论
3. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses [J] . VanGorpT., VeldmanJ., VanCalsterB., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2012,第11期

机译：超声的主观评估优于恶性指数（RMI）或卵巢恶性算法（ROMA），可将恶性附件包块与良性区分开
4. Preoperative prediction of malignancy of ovarian tumours using modified sequential non-uniform procedure [C] . Stalbovskaya, V., Ifeachor, Engineering in Medicine and Biology Society, 2007 Annual International Conference of the IEEE . 2007

机译：改良序贯非均匀程序对卵巢肿瘤恶性程度的术前预测
5. Evaluating risk of recurrent venous thromboembolism during the anticoagulation period in patients with malignancy [D] . Louzada, Martha de Lacerda. 2011

机译：评估恶性肿瘤患者抗凝治疗期间静脉血栓栓塞复发的风险
6. Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian malignancy? A case report [O] . Sepideh Khodaverdi, Soheila Amini-Moghaddam, Fariba Almassi Nokiani, 2018

机译：CA-125和CA19-9含量极高但人附睾蛋白4（HE4）正常且有卵巢恶性算法（ROMA）风险的子宫内膜异位或子宫恶性肿瘤？病例报告
7. Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass [O] . Khawla Al Musalhi, Manal Al Kindi, Faiza Al Aisary, 2016

机译：评估HE4，Ca-125，卵巢恶性肿瘤算法（ROma）的风险和恶性指数（RmI）风险在附件肿块患者术前评估中的应用

Evaluation of HE4 CA-125 Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass

摘要

著录项

相似文献

相关主题

期刊订阅